📊 Score Breakdown
Offering Ability
100
Cash Runway
65
Float Risk
55
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
59%
📜 Warrant Exercise
60%
• Massive warrant overhang: 523% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion
60%
• Major convertible overhang: 236% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
55%
• Score rose 72 points recently (worsening)
• Score already CRITICAL (94/100) — events likely imminent
💹 Market Data
Market Cap$13.60M
Shares Outstanding1.17M
Float818.1K
Cash$4.32M
Debt$2.03M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 26.0K shares
#1
Corient Private Wealth LLC
17.5K shares
#2
Warberg Asset Management LLC
2.0K shares
#3
Jane Street Group, LLC
1.6K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest133.6K
Days to Cover1.0
% of Float16.3%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ERNA
📊 ERNA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ERNA Signal Convergence & Dark Pool Activity — StonkWhisper
📄 ERNA Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.